FDA Approves Somatuline Depot (Lanreotide) for Certain Neuroendocrine Tumors
The US Food and Drug Administration (FDA) has approved Somatuline Depot (lanreotide) to treat advanced gastrointestinal neuroendocrine tumors (also known as GI carcinoids) and advanced pancreatic neuroendocrine tumors.
Abraxane plus Gemzar Combination Improves Pancreatic Cancer Survival
Researchers in Arizona and their colleagues have found that adding Abraxane (nab-paclitaxel) to a standard chemotherapy treatment helped people with advanced pancreatic cancer live longer.
Healthy Diet Linked to Lower Risk of Pancreatic Cancer
People who most closely follow healthy eating guidelines may have a lower risk of pancreatic cancer , according to a new study. Read about it here.
Society-Funded Researchers Take Aim at Pancreatic Cancer
Pancreatic cancer is a seemingly unbreachable tumor, earning it a decades-long ranking as one of the most difficult cancers to treat.
Researchers Make Discoveries in Fight against Pancreatic Cancer
New discoveries are giving researchers hope about the future of detection and treatment of pancreatic cancer, one of the most difficult cancers to find early and treat effectively.
Heavy Drinking Linked to Pancreatic Cancer
Drinking 3 or more drinks per day may raise your risk of dying from pancreatic cancer, new research by the American Cancer Society shows.
Genetics, Signaling Paths Next Frontiers in Pancreatic Cancer Treatment
New treatment theories could offer new hope against pancreatic cancer,which has traditionally been difficult to treat.